References
- Ropper AH. The Guillain-Barre syndrome. N Engl J Med 1992; 326: 1130–1136
- Haymaker W, Kernohan JW. The Landry-Guillain-Barre syndrome: clinico-pathologic of fifty fatal cases and a critique of the literature. Medicine 1949; 28: 59–141
- Cook SD, Dowling PC. The role of autoantibody and immune complexes in the pathogenesis of the Guillain-Barre syndrome. Ann Neurol 1981; 9: 70–79
- Koski CL, Gratz E, Sutherland J, Mayer RF. Clinical correlation with antiparietal-nerve myelin antibodies in Guillain-Barre syndrome. Ann Neurol 1986; 19: 573–577
- Ilyas AA, Willison HJ, Quarles RJ. Serum antibodies to gangliosides in Guillain-Barre syndrome. Ann Neurol 1988; 23: 440–447
- Svennerholm L, Friedman P. Antibody detection in Guillain-Barre syndrome. Ann Neurol 1990; 27: S35–S40, suppl
- Dubois-Dalq M, Buyse M, Buyse G, Gorce F. The action of Guillain-Barre syndrome serum on myelin: a tissue culture and electron microscopic analysis. J Neurol Sci 1971; 13: 67–83
- Harrison BM, Hansen LA, Polland JD. Demyelination induced by serum from patients with Guillain-Barre syndrome. Ann Neurol 1984; 15: 163–170
- Korn-Lubetzki I, Abramski O. Acute and chronic demyeli-nating inflammatory polyradiculopathy: association with autoimmune disease and lymphocyte response to human neu-ritogenic protein. Arch Neurol 1986; 43: 604–608
- Hirano T, Hashimoto H, Shiokawa Y. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest 1980; 66: 1437–1440
- Martinez X, Tintore M, Montalban J, Ordi J, Vilardell M, Codina A. Antibodies against gangliosides in patients with SLE and neurological manifestations. Lupus 1992; 1: 299–302
- Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990; 27: S21–S24, Suppl
- Tan EM, Cohen AS, Fries J. The 1982; revised criteria for the classification of systemic lupus erythematosus. ArlHNliS Rhuem 1982; 2531: 1271–1277
- Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558–1563
- Shoenfeld Y, Rauch J, Massicott H, Datta SK, Andre-Schwartz J, Stellar BD, Schwartz RS. Polyspecificty of monoclonal lupus autoantibodies by human hybridomas. N Engl J Med 1983; 308: 414–420
- Sammaritano LR, Gharavi AE. Antiphospholipid antibody syndrome. Clin Lab Med 1992; 12: 41–57
- Tomer Y, Kessler A, Eyal A, Many A, Shoenfeld Y. Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol 1991; 18: 95–97
- Tomer Y, Buskila D, Shoenfeld Y. Pathogenic significance and diagnostic value of lupus autoantibodies. Int Arch Allergy Immunol 1993; 100: 293–306
- Levine SR, Deegan MJ, Futrell N, Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181–1189
- Asherson RA, Derksen RHWM, Harris N, Bouma BN, Gharavi AE, Kater L, Hughes GRV. Chorea in systemic lupus erythematosus and “lupus-like” disease: association with antiphospholipid antibodies. Sem Arthritis Rheum 1987; 16: 253–259
- Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987; 44: 876–883
- Tomer Y, Shoenfeld Y. Successful treatment of psychosis secondary to SLE by high dose intravenous immunoglobulin. Clin Exp Rheumatol 1992; 10: 391–393
- Chaleomchan W, Hemachudha T, Sakulramrung R, Deesom-Chok U. Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases. J Neurol Sci 1990; 96: 143–151
- Frampton G, Winer JB, Cameron JS, Hughes RA. Severe Guillain-Barre syndrome: an association with IgA anticardiolipin antibody in a series of 92 patients. J Neuroim-munol 1988; 19: 133–139
- Latov N, Koski CL, Walicke PA. Guillain-Barre syndrome and parenteral gangliosides. Lancet 1991; 2: 757
- Tomer Y, Shoenfeld Y. The significance of natural autoantibodies. Immunol Invest 1988; 17: 389–424
- Hundert I, Bakimer R, Amital-Teplizki H, Slor H, Yassur Y, Palestine A, Nussenblatt RB, Shoenfeld Y. Antinuclear autoantibodies in uveitis. Clin Exp Rheumatol 1989; 7: 237–241
- Amital Teplizki H, Sela B, Shoenfeld Y. Autoantibodies to brain and polynucleotides in patients with schizophrenia: a puzzle. Immunol Res 1992; 11: 66–73